QC
EVH icon

Quadrature Capital’s Evolent Health EVH Stock Holding History

Quadrature Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-159,815
Closed -$639K – 1530
2025
Q4 		$639K Buy
159,815
+89,742
+128% +$499K 0.01% 631
2025
Q3 		$592K Buy
70,073
+57,304
+449% +$556K 0.01% 482
2025
Q2 		$144K Sell
12,769
-428
-3% -$3.93K ﹤0.01% 861
2025
Q1 		$125K Sell
13,197
-24,144
-65% -$244K ﹤0.01% 912
2024
Q4 		$420K Buy
+37,341
New +$656K 0.01% 632
2022
Q4 		– Sell
-16,995
Closed -$611K – 926
2022
Q3 		$611K Buy
+16,995
New +$599K 0.02% 468
2021
Q2 		– Sell
-15,499
Closed -$313K – 1028
2021
Q1 		$313K Sell
15,499
-19,050
-55% -$362K 0.02% 613
2020
Q4 		$554K Sell
34,549
-37,237
-52% -$492K 0.03% 454
2020
Q3 		$891K Buy
+71,786
New +$844K 0.05% 378
2019
Q2 		– Sell
-22,909
Closed -$288K – 508
2019
Q1 		$288K Buy
+22,909
New +$363K 0.02% 416

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's EVH Position: Q1 2026 in Review

Quadrature Capital sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 159,815 shares — an estimated $639K sold.

Quadrature Capital first reported a position in EVH in Q1 2019 and held it in 10 quarters. The position peaked at $891K in Q3 2020. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Quadrature Capital reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 159,815 Evolent Health shares in Q1 2026, an estimated $639K.
  • Quadrature Capital first reported a position in Evolent Health in Q1 2019 and held it in 10 quarters.
  • Quadrature Capital's Evolent Health position peaked at $891K in Q3 2020.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.